Recall: D-0077-2027
Class II - Potentially Harmful
Class IIClassification
2026-10-07Initiated
OngoingStatus
MACLEODS PHARMA USA, INCFirm
Product
Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only, Manufactured for : Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd, Daman, 396210, India
Reason
Failed Dissolution Specifications.
Distribution
Nationwide in the USA
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.